Balance Sheet Data

AnaptysBio, Inc. (ANAB)

$16.36

-0.06 (-0.37%)

Year
A/P
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Actual
2023
Projected
2024
Projected
2025
Projected
2026
Projected
2027
Projected
Total Cash 427.08374.23393.65548.10441.241,164.693,488.3110,447.6331,291.0893,718.08
Total Cash (%)
Account Receivables 0.170.282.612.200.361.073.219.6228.8186.27
Account Receivables (%)
Inventories ----------
Inventories (%)
Accounts Payable 5.4416.244.221.742.7821.4064.09191.95574.901,721.84
Accounts Payable (%)
Capital Expenditure -1.06-0.81-0.57-1.37-0.36-2.32-6.96-20.85-62.45-187.04
Capital Expenditure (%)



To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows) and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.